BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 38758552)

  • 1. ThyroSeq overview on indeterminate thyroid nodules: An institutional experience.
    Sirotnikov S; Griffith CC; Lubin D; Zhang C; Saba NF; Li D; Kornfield A; Chen A; Shi Q
    Diagn Cytopathol; 2024 Jul; 52(7):353-361. PubMed ID: 38554032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness.
    Liu R; Zhu G; Tan J; Shen X; Xing M
    J Natl Cancer Inst; 2024 May; 116(5):694-701. PubMed ID: 38113409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytologic features of differentiated high-grade thyroid carcinoma: A multi-institutional study of 40 cases.
    Torous VF; Jitpasutham T; Baloch Z; Cantley RL; Kerr DA; Liu X; Maleki Z; Merkin R; Nosé V; Pantanowitz L; Resta IT; Rossi ED; Faquin WC
    Cancer Cytopathol; 2024 Jun; ():. PubMed ID: 38873907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS Allelic Variants in Biliary Tract Cancers.
    Moffat GT; Hu ZI; Meric-Bernstam F; Kong EK; Pavlick D; Ross JS; Murugesan K; Kwong L; De Armas AD; Korkut A; Javle M; Knox JJ
    JAMA Netw Open; 2024 May; 7(5):e249840. PubMed ID: 38709532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Droplet Digital PCR for the Detection of
    Min YK; Kim JK; Park KS; Kim JW
    Ann Lab Med; 2024 Jun; ():. PubMed ID: 38872331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathology of Thyroid Tumors: Old Problems and New Concepts.
    Hernandez-Prera JC
    Clin Lab Med; 2024 Jun; 44(2):305-324. PubMed ID: 38821646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of Thyroid Cancer.
    Fu G; Chazen RS; MacMillan C; Witterick IJ
    JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.
    Fu G; Chazen RS; Monteiro E; Vescan A; Freeman JL; Witterick IJ; MacMillan C
    JAMA Netw Open; 2023 Jul; 6(7):e2323500. PubMed ID: 37505499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2023 Bethesda System for Reporting Thyroid Cytopathology.
    Ali SZ; Baloch ZW; Cochand-Priollet B; Schmitt FC; Vielh P; VanderLaan PA
    Thyroid; 2023 Sep; 33(9):1039-1044. PubMed ID: 37427847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of BRAF targeting agents in advanced anaplastic thyroid cancer: a multi-institutional retrospective study in Taiwan.
    Chang CF; Yang MH; Lee JH; Shih SR; Lin CH; Chen CP; Wu CE; Lu JY
    Am J Cancer Res; 2022; 12(11):5342-5350. PubMed ID: 36504909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Effective is the Use of Molecular Testing in Preoperative Decision Making for Management of Indeterminate Thyroid Nodules?
    Steinmetz D; Kim M; Choi JH; Yeager T; Samuel K; Khajoueinejad N; Buseck A; Imtiaz S; Fernandez-Ranvier G; Lee D; Owen R; Taye A
    World J Surg; 2022 Dec; 46(12):3043-3050. PubMed ID: 36167834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
    Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens.
    Fu G; Chazen RS; MacMillan C; Witterick IJ
    JAMA Netw Open; 2021 Oct; 4(10):e2127243. PubMed ID: 34613404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial.
    Livhits MJ; Zhu CY; Kuo EJ; Nguyen DT; Kim J; Tseng CH; Leung AM; Rao J; Levin M; Douek ML; Beckett KR; Cheung DS; Gofnung YA; Smooke-Praw S; Yeh MW
    JAMA Oncol; 2021 Jan; 7(1):70-77. PubMed ID: 33300952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.
    Kaya C; Dorsaint P; Mercurio S; Campbell AM; Eng KW; Nikiforova MN; Elemento O; Nikiforov YE; Sboner A
    Thyroid; 2021 Apr; 31(4):589-595. PubMed ID: 32948110
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular Profiling of Thyroid Nodules-Are These Findings Meaningful, or Merely Measurable?: A Review.
    Morris LGT
    JAMA Otolaryngol Head Neck Surg; 2020 Sep; 146(9):845-850. PubMed ID: 32745207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Determinants of Thyroid Nodules with Indeterminate Cytology and
    Hernandez-Prera JC; Valderrabano P; Creed JH; de la Iglesia JV; Slebos RJC; Centeno BA; Tarasova V; Hallanger-Johnson J; Veloski C; Otto KJ; Wenig BM; Yoder SJ; Lam CA; Park DS; Anderson AR; Raghunand N; Berglund A; Caudell J; Gerke TA; Chung CH
    Thyroid; 2021 Jan; 31(1):36-49. PubMed ID: 32689909
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.